Nav: Home

Pregnant women with depression are more than 3 times more likely to use cannabis

March 03, 2020

March 3, 2020 - Cannabis use is much more common among pregnant women with depression and pregnant women with depression are more than 3 times more likely to use cannabis than those without depression, according to a new study at Columbia University Mailman School of Public Health. Despite data linking cannabis and depression in many populations, this is the first study to examine this relationship among pregnant women in a nationally representative sample. The findings are online in the journal Drug and Alcohol Dependence.

Data were drawn from the 2005-2018 National Survey on Drug Use and Health (NSDUH), an annual survey of persons ages 12 and older in the US. Pregnant women were categorized as a current cannabis user if they responded they has used marijuana at least once during the past 30 days. The study, conducted with colleagues at The City University of New York, also investigated whether the relationship between depression and cannabis use differed by age, other sociodemographic characteristics, and perception of risk associated with cannabis use.

"Our findings are timely given rapidly shifting perceptions about risks associated with cannabis use and its legalization," said Renee Goodwin, PhD, in the Department of Epidemiology at Columbia Mailman School. "We found the prevalence of cannabis use was much higher among those with depression who perceived no risk (24 percent) relative to those who perceived moderate-great risk associated with use (5.5 percent)."

Among pregnant women without depression, those who perceived no risk had higher levels of use (16.5 percent) compared with those who perceived moderate-great risk (0.9 percent), though both these levels were substantially lower than among women with depression.

Depression appears to increase vulnerability to cannabis use even among pregnant women who perceive substantial risk. "Perception of greater risk associated with regular use seems to be a barrier to cannabis use, though pregnant women with depression who perceived moderate-great risk associated with regular cannabis use were more than 6 times as likely to use cannabis than those without depression. This suggests that depression may lead to use even among those who perceive high risk," noted Goodwin. "With legalization, the degree to which dangers are thought to be linked with cannabis use appear to be declining in the U.S. overall, and this may also apply to pregnant women."

Cannabis use was significantly more common among pregnant women with, compared to without, depression. Over one in ten (13 percent) pregnant women with a major depressive episode reported past-month cannabis use compared with 4 percent without depression who reported using cannabis. This was the case across all sociodemographic subgroups.

Approximately one in four pregnant teens with depression used cannabis in the past month. "As brain development is ongoing until age 25, cannabis use in this group may increase risks for both mother and offspring," she noted." "Our results provide recent nationally representative estimates suggesting that education and intervention efforts should be targeted at pregnant teens."

"Education about risks associated with cannabis use during pregnancy for both mother and offspring, especially among women with prenatal depression, are needed as cannabis is rapidly being legalized across the U.S. and increases among pregnant women have previously been reported," suggested Goodwin.
-end-
Co- authors are Jiaqi Zhu, Zoe Heisler, Katarzyna Wyka, The City University of New York, Melody Wu of Columbia Mailman School; Torri Metz, University of Utah Health; and Rina Das Eiden, Pennsylvania State University.

This work was supported by the National Institutes of Health/ National Institute on Drug Abuse [grant number #DA20892].

Columbia University Mailman School of Public Health

Founded in 1922, the Columbia University Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Columbia Mailman School is the seventh largest recipient of NIH grants among schools of public health. Its nearly 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change and health, and public health preparedness. It is a leader in public health education with more than 1,300 graduate students from 55 nations pursuing a variety of master's and doctoral degree programs. The Columbia Mailman School is also home to numerous world-renowned research centers, including ICAP and the Center for Infection and Immunity. For more information, please visit http://www.mailman.columbia.edu.

Columbia University's Mailman School of Public Health

Related Depression Articles:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.
Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.
Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.
Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.
A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.
Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.
Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.
Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.
Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.
CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.
More Depression News and Depression Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.